/Investor DB

Keiretsu Capital — 2015 Investments

2 investments dated 2015 · listed companies and verified rows first · show all

Embera NeuroTherapeuticsemberaneuro.comSeries A · Feb 2015 · $2M

Clinical-stage specialty pharma developing a combination drug to treat a range of addictions, licensed from LSU Health Sciences Center.

BiotechSudbury, US

Robert B. Linke(Executive Officer, Director)

BoardRoss Barrett(Director)Franz Hefti(Director)John Beaird(Director)Joseph Lovett(Director)

Co-investorsInnovation CatalystKeiretsu ForumLouisiana Funds

LumiTheralumithera.comSeries A · Oct 2015

LumiThera develops the Valeda Light Delivery System, an FDA-authorized photobiomodulation (PBM) device that applies multiple light wavelengths to treat early and intermediate dry age-related macular degeneration (AMD).

BiotechHealthtechMedical DevicesPoulsbo, US

Tracy Puckett(Executive Officer)Clark Tedford(Executive Officer, Director)inScott Bradley(Executive Officer)inDuane Morrison(Executive Officer)inCindy Croissant(Executive Officer)Ryan Montecucco(Executive Officer)

Co-investors3E Bioventures CapitalEFung CapitalKeiretsu ForumLife Sciences Greenhouse InvestmentsImagine Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.